DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Noom Med vs OrderlyMeds: November 2026 prices compared

As of November 20, 2026, from each program’s own page: on compounded tirzepatide, month to month and all-in, Noom Med charges $299 per 28-day cycle and OrderlyMeds $299 a month: $3,887 against $3,588 for a year, so OrderlyMeds costs $299 less over a year.

Released · Last reviewed · how we verify

On compounded semaglutide, month to month and all-in, Noom Med charges $249 per 28-day cycle and OrderlyMeds $149 a month: $3,237 against $1,788 for a year, so OrderlyMeds costs $1,449 less over a year.

Noom Med and OrderlyMeds, measure by measure

Noom Med and OrderlyMeds side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureNoom MedOrderlyMeds
Tirzepatide, month to month$299 (per 28-day cycle)$299 (per month)
Tirzepatide, lowest printed$299 (per 4 weeks, billed $897 every 12 weeks)$149 (2-month new-customer offer, $299)
Semaglutide, month to month$249 (per 28-day cycle)$149 (per month)
Semaglutide, lowest printed$249 (per 4 weeks, billed every 12 weeks)$74 (2-month new-customer offer, $149)
Dose pricingpriced by dose or not statedsame price at every dose
Membership or program feenonenone
Computed score21.4 of 40 (position 10 of 27)27.9 of 40 (position 6 of 27)
FDA warning lettersnone listed728291 (2026-06-08)
November 20 readfirst-party read, changedfirst-party read

Strengths and limitations: which fits whom

Noom Med bills every 28 days, which adds a 13th charge to the year. OrderlyMeds prints one price at every dose with no membership, so a dose increase does not change the bill. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

What changed since August

The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.

What changed since the August 2026 capture (maintenance-dose all-in figure then; month-to-month all-in figure read November 20, 2026)
ProgramMedicationAugust 5–10, 2026November 20, 2026
Noom Medtirzepatide—$299
Noom Medsemaglutide—$249
OrderlyMedstirzepatide—$299
OrderlyMedssemaglutide—$149

Regulatory record

FDA’s warning-letter index lists warning letter 728291 (dated June 8, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to OrderlyMeds; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Check Noom Med’s current prices ↗
Check OrderlyMeds’s current prices ↗

Frequently asked

Which is cheaper, Noom Med or OrderlyMeds?

On compounded tirzepatide, month to month and all-in, Noom Med charges $299 per 28-day cycle and OrderlyMeds $299 a month: $3,887 against $3,588 for a year, so OrderlyMeds costs $299 less over a year. On compounded semaglutide, month to month and all-in, Noom Med charges $249 per 28-day cycle and OrderlyMeds $149 a month: $3,237 against $1,788 for a year, so OrderlyMeds costs $1,449 less over a year.

Do Noom Med and OrderlyMeds charge a membership fee?

Noom Med: no membership fee; OrderlyMeds: no membership fee. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are Noom Med and OrderlyMeds medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

Noom Med recordNoom Med alternativesOrderlyMeds recordOrderlyMeds alternativesAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.